GAL3ST1 and metachromatic leukodystrophy: This study describes the identification and characterization of potent and selective drugs against CST to counter the accumulation of sulfatides responsible for myelin sheath disturbances in the nervous system as part of the strategy to develop substrate reduction therapy for MLD.